Both the Finnish and the U.S. bird flu vaccines are made by CSL Seqirus but are different vaccines. In the summer, U.S. officials stockpiled 4.8 million doses of the vaccine that officials said was effective against circulating H5N1 strains. In October, the U.S. issued a $72 million grant to three manufacturers to double the nation's stockpile.

State officials are warning the public about a suspected bird flu outbreak that’s infected over 60 Canada geese, swans and ducks.